Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 96,300 shares, an increase of 20.7% from the May 31st total of 79,800 shares. Approximately 1.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,130,000 shares, the short-interest ratio is currently 0.1 days.
Qualigen Therapeutics Stock Performance
Qualigen Therapeutics stock opened at $0.17 on Tuesday. Qualigen Therapeutics has a twelve month low of $0.14 and a twelve month high of $1.26. The company’s 50-day moving average price is $0.25 and its 200-day moving average price is $0.39.
Qualigen Therapeutics Company Profile
See Also
- Five stocks we like better than Qualigen Therapeutics
- How to Calculate Return on Investment (ROI)
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- P/E Ratio Calculation: How to Assess Stocks
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.